Starting July 1, Medicare will cover GLP-1 obesity drugs like Wegovy, opening up access for millions of seniors who previously couldn't afford them.
Health & Wellness News
A Queensland Health resource offers a simple whole-body workout you can do at home with just a mat and a chair. It's designed to leave you feeling energized without any gym membership or special equipment required. A great option for anyone looking to move more without added cost or complexity.
A registered dietitian breaks down 19 manageable changes — think reading nutrition labels and moderating alcohol — that can meaningfully improve your diet without a full overhaul. The advice draws on CDC and FDA guidance, keeping suggestions practical for everyday life.
Researchers are working on new formulations of GLP-1 drugs that could reduce how often patients need to take them — potentially shifting from weekly injections to just once a quarter.
A psychological phenomenon called "ghost fat" is being reported among people who've lost significant weight on GLP-1 drugs — they continue to see themselves as overweight even after the pounds are gone, similar to body dysmorphia.
A large observational study found that breast cancer patients who took GLP-1 drugs had better survival outcomes compared to those who didn't. Researchers say the findings are promising but call for formal clinical trials to confirm whether the drugs are actually responsible for the benefit.
A therapist who specializes in eating disorders addresses the complicated pull that GLP-1 weight-loss drugs can have for people already struggling with their relationship with food.
A new at-home genetic test called MyPhenome claims it can tell you whether your body is likely to respond to GLP-1 weight-loss drugs before you spend thousands of dollars on them.